Context Therapeutics's total assets for Q4 2024 were $98.13M, an increase of 13.66% from the previous quarter. CNTX total liabilities were $2.86M for the fiscal quarter, a 15.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.